🕒 Wednesday 7 May 2025 Wed, 7 May 2025

Maas Group Holdings has reaffirmed its FY25 underlying EBITDA guidance of $215 million to $245 million, driven by recent acquisitions and growth in construction materials and renewable energy sectors.

Credit Corp Group maintains its FY25 NPAT guidance amid operational gains in US debt buying and cautious optimism in Australian/New Zealand lending markets.

Regis Healthcare reveals strong first-half FY25 financial results with rising occupancy and earnings, while gearing up for significant regulatory reforms under the new Aged Care Act effective July 2025.

Super Retail Group reports a 3.1% like-for-like sales growth in H2 FY25, driven by key brands and strategic investments in its omni-retail network and supply chain.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

Nexus Minerals Limited has updated its exploration progress with significant gold resources at Wallbrook and Pinnacles projects, alongside promising new discoveries and ongoing drilling campaigns.

NSX Limited has successfully closed a $1.13 million capital raising placement, issuing 45.2 million shares at 2.5 cents each, aligning with its prospectus targets. This move strengthens the company’s financial footing as it continues to develop its alternative stock exchange platform.

Spectur Limited appoints Anthony Schmidt as CEO, accelerating its transition to a scalable SaaS model and targeting operational cashflow neutrality by mid-2025 amid a $3 billion addressable market.

Southern Cross Gold Consolidated has successfully closed the first tranche of a private placement, raising C$88.8 million to advance its Sunday Creek Gold-Antimony Project in Victoria, Australia. The funds will support drilling, resource definition, and early development milestones.

360 Capital Group has extended the closing date for its Off-Market Equal Access Buy-Back by one week to 21 May 2025, offering eligible securityholders additional time to participate. This adjustment also shifts key dates for payment and cancellation of securities.

Tivan Limited has had its trading suspension lifted following the announcement of a binding joint venture and funding agreement for its Speewah Fluorite Project, signaling renewed momentum for the company.

Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.

Tivan Limited has locked in a $5 million share placement and signed a non-binding term sheet for a $51.3 million equity investment to fund the Speewah Fluorite Project, marking a significant step in its development plans.

Tivan Limited and Sumitomo Corporation have formalised a joint venture to develop the Speewah Fluorite Project in Western Australia, marking a major step toward establishing Australia’s inaugural fluorite mining and processing operation.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Global Data Centre Group updates its distribution guidance following the AirTrunk divestment, factoring in operational costs and risk reserves that temper immediate payouts.

SelfWealth Ltd has officially been acquired by Syfe’s holding company, with shareholders receiving $0.28 per share and the company set to delist from the ASX on May 8.

Santana Minerals reports promising assay results from recent drilling at its Rise and Shine deposit, revealing extensions of high-grade gold mineralisation beyond current resource boundaries. These findings hint at significant upside potential for the project’s resource base.

ARC Funds Limited has secured $1.4 million through equity and debt to complete a strategic acquisition of a majority stake in The Term Deposit Shop, expanding its footprint in Australia's term deposit market.

Tivan Limited’s shares have been suspended at the company’s request pending a major joint venture announcement and its response to an ASX compliance query.

National Australia Bank has reported robust half-year results with cash earnings of $3.58 billion and announced a fully franked interim dividend of 85 cents per share, underscoring its strong market position and strategic clarity.

Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.

Echo IQ has raised $17.3 million through a strongly supported institutional placement to fund US commercialization and FDA approval efforts for its EchoSolv AI cardiology products.

SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.